Skip to main content
. 2018 Oct 30;8:16024. doi: 10.1038/s41598-018-34298-7

Table 3.

Test performance in comparison to BSI diagnosis according to the adapted ECDC criteria.

BSI BC BAC BSI SeptiFast BC + BAC BSI BC + SeptiFast
neg pos neg pos neg pos neg pos neg pos
neg 115 9 119 5 124 0 111 13 115 9
pos 27 42 11 58 27 42 3 66 16 53
ROC-AUC (95% CI) 0.77 (0.70–0.83) 0.90 (0.85–0.94) a 0.80 (0.74–0.86) 0.93 (0.88–0.96) b 0.85 (0.79–0.90) c
% sensitivity (95% CI) 60.9 (48.4–72.4) 84.1 (73.3–91.8) 60.9 (48.4–72.4) 95.7 (87.8–99.1) 76.8 (65.1–86.1)
% specificity (95% CI) 92.7 (86.7–96.6) 96.0 (90.8–98.7) 100 (97.1–100) 89.5 (82.7–94.3) 92.7 (86.7–96.6)
% PPV (95% CI) 82.4 (70.8–90.0) 92.1 (83.0–96.5) 100 (−) 83.5 (75.2–89.5) 85.5 (75.6–91.8)
% NPV (95% CI) 81.0 (76.0–85.2) 91.5 (86.3–94.9) 82.1 (77.4–86.0) 97.4 (92.4–99.1) 87.8 (82.3–91.7)

BSI = bloodstream infection; ECDC = European Centre for Disease Prevention and Control; BC = blood culture; ROC-AUC = receiver operating characteristic-area under the curve; PPV = positive predictive value; NPV = negative predictive value; CI = confidence interval; aBAC BSI vs. BC: p = 0.004 and BAC BSI vs. SeptiFast: p = 0.034, bBC + BAC BSI vs. BC: p < 0.001 and BC + BAC BSI vs. BC + SeptiFast: p = 0.011, cBC + SeptiFast vs. BC: p < 0.001 as assessed by the Hanley & McNeil test.